PUCCETTI, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 8.762
EU - Europa 7.250
AS - Asia 4.186
SA - Sud America 635
AF - Africa 140
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 6
Totale 20.989
Nazione #
US - Stati Uniti d'America 8.616
CN - Cina 1.540
GB - Regno Unito 1.509
RU - Federazione Russa 1.491
SG - Singapore 1.310
IE - Irlanda 960
IT - Italia 899
UA - Ucraina 592
SE - Svezia 567
BR - Brasile 528
FR - Francia 480
DE - Germania 332
HK - Hong Kong 322
VN - Vietnam 307
KR - Corea 226
FI - Finlandia 204
BD - Bangladesh 103
IN - India 93
CA - Canada 83
ZA - Sudafrica 66
TR - Turchia 52
NL - Olanda 40
JP - Giappone 39
IQ - Iraq 38
MX - Messico 37
AR - Argentina 28
ES - Italia 26
PL - Polonia 26
BE - Belgio 25
NG - Nigeria 25
PK - Pakistan 19
AT - Austria 17
MY - Malesia 17
CZ - Repubblica Ceca 16
ID - Indonesia 16
EC - Ecuador 15
CO - Colombia 14
VE - Venezuela 14
KE - Kenya 13
MA - Marocco 13
SA - Arabia Saudita 13
UZ - Uzbekistan 11
AU - Australia 9
CL - Cile 9
LT - Lituania 9
PH - Filippine 9
PY - Paraguay 8
RO - Romania 8
BO - Bolivia 7
CH - Svizzera 7
ET - Etiopia 7
JM - Giamaica 7
PE - Perù 7
IL - Israele 6
KG - Kirghizistan 6
KZ - Kazakistan 6
OM - Oman 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
DZ - Algeria 5
EU - Europa 5
HR - Croazia 5
JO - Giordania 5
PT - Portogallo 5
DO - Repubblica Dominicana 4
IR - Iran 4
NI - Nicaragua 4
NP - Nepal 4
UY - Uruguay 4
BG - Bulgaria 3
BN - Brunei Darussalam 3
CI - Costa d'Avorio 3
EG - Egitto 3
KH - Cambogia 3
LB - Libano 3
LK - Sri Lanka 3
LV - Lettonia 3
PA - Panama 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
AZ - Azerbaigian 2
BH - Bahrain 2
CY - Cipro 2
GR - Grecia 2
HN - Honduras 2
IM - Isola di Man 2
MD - Moldavia 2
MT - Malta 2
NO - Norvegia 2
PS - Palestinian Territory 2
RS - Serbia 2
AM - Armenia 1
BB - Barbados 1
BY - Bielorussia 1
CM - Camerun 1
CU - Cuba 1
GE - Georgia 1
GI - Gibilterra 1
GY - Guiana 1
HU - Ungheria 1
Totale 20.972
Città #
Southend 1.305
Dallas 1.221
Dublin 959
Fairfield 842
Singapore 766
Ashburn 572
Chandler 469
Jacksonville 464
Santa Clara 444
Woodbridge 395
Moscow 375
San Jose 348
Beijing 347
Wilmington 344
Houston 327
Hong Kong 313
Seattle 311
Hefei 301
Cambridge 248
Seoul 224
Ann Arbor 223
Princeton 191
New York 181
Nanjing 176
The Dalles 143
Siena 129
Los Angeles 115
Lauterbourg 100
Milan 97
Ho Chi Minh City 93
Hanoi 81
Helsinki 78
San Mateo 77
Shanghai 71
Buffalo 69
Munich 64
Boardman 61
San Diego 60
Florence 59
Johannesburg 56
São Paulo 50
Council Bluffs 46
Nanchang 41
Hebei 37
Rome 37
Bengaluru 35
Tokyo 35
Changsha 34
Toronto 33
Menlo Park 31
Turku 30
Columbus 29
Chicago 28
Orem 28
Lancaster 27
London 27
San Francisco 26
Shenyang 26
Jiaxing 25
Dearborn 24
Tianjin 23
Brussels 22
Abuja 21
Nuremberg 19
Brooklyn 18
Hangzhou 17
Kunming 17
Warsaw 17
Düsseldorf 16
Frankfurt am Main 16
Guangzhou 16
Rio de Janeiro 16
Da Nang 15
Denver 15
Chennai 14
Haiphong 14
Istanbul 14
Jinan 14
Montreal 14
Manchester 13
Málaga 13
Ningbo 13
Philadelphia 13
Washington 13
Baghdad 12
Boston 12
Brno 12
Mexico City 12
Norwalk 12
Stockholm 12
Turin 12
Atlanta 11
Belo Horizonte 11
Brasília 11
Grosseto 11
Izmir 11
Paris 11
Redondo Beach 11
Vienna 11
Mumbai 10
Totale 13.913
Nome #
Endogenous thrombin potential and screening parameters of coagulation [Potenziale endogeno di trombina e parametri di screening della coagulazione] 418
Potenziale endogeno di trombina (ETP) e parametri di screening della coagulazione. Comparazione tra INR, D-Dimero ed ETP in una popolazione di soggetti anticoagulati con Warfarin per fibrillazione atriale cronica. 403
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 363
Decreased plasma endogenous soluble RAGE, and enhanced adipokine secretion, oxidative stress and platelet/coagulative activation identify non-alcoholic fatty liver disease among patients with familial combined hyperlipidemia and/or metabolic syndrome 320
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 308
Neurohumoral improvement and torsional dynamics in patients with heart failure after treatment with levosimendan 301
Residual peripheral blood CD26+leukemic stem cells in chronic myeloid leukemia patients during TKI therapy and during treatment-free remission 291
Quantitative evaluation of microvessels in Behcet's disease 291
Atherothrombotic Risk and TKIs Treatment In Chronic Myeloid Leukemia Patients: A Role For Genetic Predisposition and Pro-Inflammatory/Pro-Oxidative Status? 288
Brain natriuretic peptide and other risk markers for outcome assessment in patients with non-ST-elevation coronary syndromes and preserved systolic function. 286
Genetic predisposition and induced pro-inflammatory/pro-oxidative status may play a role in increased atherothrombotic events in nilotinib treated chronic myeloid leukemia patients 279
Effect of two single oral doses of mesoglycan on the coagulative and fibrinolytic system in human. A pharmacodynamic study [Azione di due dosi orali singole di mesoglicano sul sistema coagulativo-fibrinolitico dell'uomo. Studio farmacodinamico] 275
Genetic influence in antithrombotic actions of atorvastatin in hypercholesterolaemia 273
Atherothrombotic risk assessment during tyrosine kinase inhibitors treatment in chronic myeloid leukemia patients: new insight? 269
Cytokines in acute coronary syndromes 257
Takayasu's arteritis: case report of a patient with recurrent subclavian steal syndrome 253
Cardiac dysautonomia and arterial distensibility in essential hypertensives 251
Genetic predisposition and induced pro-inflammatory/pro-oxidative status may explain increased atherothrombotic risk during TKI treatment in chronic myeloid leukemia patients 248
Atorvastatin reduces platelet-oxidized-LDL receptor expression in hypercholesterolaemic patients 248
Analisi morfometrica ultrastrutturale di piastrine e leucociti nel paziente sottoposto ad angioplastica coronarica e nell'arteriopatia obliterante periferica 241
Effects of fluoxetine treatment on carbohydrate metabolism in human blood platelets: a 1H-NMR study 240
Heart failure and chronic kidney disease in a registry of internal medicine wards 233
A case of acquired factor XIII deficiency secondary to plasmablastic lymphoma 227
Effects of carvedilol therapy on restrictive diastolic filling pattern in chronic heart failure 224
Coagulative, fibrinolytic and metabolic pattern in patients with central retinal vein occlusion 224
Effect of atorvastatin on different fibrinolyis mechanisms in hypercholesterolemic subjects 222
Effects of carvedilol on left ventricular remodeling and systolic function in elderly patients with heart failure 221
A fatal unsuspected case of acquired A hemophilia. Misleading role of therapy with acetylsalicylic acid? 220
L’apoptosi linfocitaria nell’infarto miocardico acuto senza sopraelevazione del tratto ST 219
Definizione di pattern videocapillaroscopici (VCS) di normalità nel microcircolo cutaneo. Stratificazione secondo l'età 216
Long-Term use of ticagrelor in patients with prior myocardial infarction 216
Cardiac papillary fibroelastoma: An unusual source of cerebral embolism solved with local fibrinolysis 216
Different effect of statins on platelet oxidized-LDL receptor (CD36 and LOX-1) expression in hypercholesterolemic subjects 213
Lectin-like oxidized-LDL receptor-1 (LOX-1) polymorphisms influence cardiovascular events rate during statin treatment 212
Chronic urticaria and blastocystis hominis infection. A case report 210
Comparison of disease clusters in two elderly populations hospitalized in 2008 and 2010 208
Different mechanisms of fibrinolysis impairment among dyslipidemic subjects 204
Cranial osteolytic metastases as the only recurrence of gastric carcinoma 203
Genetic involvement in statins induced myopathy. Preliminary data from an observational case-control study 201
Potenziale endogeno di trombina e parametri di screening della coagulazione. 200
Systemic adenosine increase during cold pressor test is dependent on sympathetic activation 199
Plasma brain natriuretic peptide levels in coronary heart disease with preserved systolic function 196
Bosentan treatment on Raynaud Phenomenon and Skin Fibrosis in Patients with Systemic Sclerosis and with Pulmonary Arterial Hypertension: an open-label, observational, retrospective study 196
Dyslipidemias and fibrinolysis. 196
Genetic modulation of anti-inflammatory effects of atorvastatin; probably a multi-gene condition 195
Diurnal rhythm of the anticoagulant effect of continuous i.v. infusion of unfractioned heparin: a possible role for platelet activation 190
Circadian rhythm during unfractioned heparin i.v.infusion in man: modification by ASA or pentoxifylline per os 189
Different effect induced by treatment with statins on monocyte tissue factor expression in hypercholesterolemic subjects 189
Variazioni diurne dell’ effetto anticoagulante dell’ eparina non frazionata in corso di infusione continua e.v. nell’ uomo. Modificazioni indotte da acido acetlsalicico per os 189
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly 188
Central Retinal Vein Occlusion and Prothrombotic Factors 187
Complement activation in hypercholesterolemia 186
Platelet hyperactivity after statin treatment discontinuation 185
Real-life experience of edoxaban treatment for venous thromboembolism (VTE)/pulmonary embolism (PE) in patients with isolated positive Lupus Anticoagulant (LAC) during the COVID-19 pandemic lockdown in Italy 184
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation 184
Structural and functional abnormality of systemic microvessels in cardiac syndrome X 182
Protective effects of novel metal-nonoates on the cellular components of the vascular system 182
Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study 181
Time-dependent effect of statins on platelet function in hypercholesterolaemia 181
Increased TNF-alpha production by peripheral blood mononuclear cells in patients with Krabbe's disease: effect of psychosine 180
Pharmacogenetics of statins therapy 179
In-hospital death according to dementia diagnosis in acutely ill elderly patients: the REPOSI study 177
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 176
Prevalence and appropriateness of drug prescriptions for peptic ulcer and gastro-esophageal reflux disease in a cohort of hospitalized elderly 176
Safety of COVID-19 mRNA vaccination in patients with history of acquired hemophilia A: a case series 175
T cell activation and enhanced apoptosis in non-ST elevation myocardi infarction 173
In-hospital death and adverse clinical events in elderly patients according to disease clustering: the REPOSI study 172
Transmitral and pulmonary venous flow study in elite male runners and young adults 172
Enhanced lipid peroxidation and platelet activation as potential contributors to increased cardiovascular risk in the low-HDL phenotype 172
Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI 170
Circulating esRAGE is Associated with a Pro-Inflammatory/Pro-Atherothrombotic Profile in Familial Combined Hyperlipidemia Patients with Non-alcoholic Fatty Liver Disease 168
Evidences of new risk factors for retinal vein thrombosis 167
Levosimendan improves pro/anti-inflammatory cytokines imbalance in male patients with advanced heart failure. A randomized, double-blind, placebo-controlled study 165
Statins discontinuation in compliant chronic users induces atherothrombotic profile despite baseline clinical setting and treatments 162
Effect of diet and treatment with statins on platelet-dependent thrombin generation in hypercholesterolemic subjects 162
Pro-inflammatory/anti-inflammatory cytokine imbalance in acute coronary syndromes 162
Genetics of the coenzyme Q10 pathway and rosuvastatin-induced muscle effects 159
Safety of long-term simvastatin discontinuation 158
Genetic influence in statin intolerance 158
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia 157
Diatolic filling in hypertrophied hearts of elite runners: an echo-doppler study 157
Microvascular assessment in Behcet disease: videocapillaroscopic study. 156
Role of platelets in tissue factor expression by monocytes in normal and hypercholesterolemic subjects. In vitro effect of cerivastatin 155
Role of genetic factors in statins side-effects 154
Psoriasis successfully treated with guselkumab in a patient with systemic lupus erythematosus and acquired hemophilia A 154
Mechanism for antiplatelet action of statins 151
Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards 149
Pro-Inflammatory and Pro-Oxidative Changes During Nilotinib Treatment in CML Patients: Results of a Prospective Multicenter Front-Line TKIs Study (KIARO Study) 147
Pro/anti-inflammatory cytokine imbalance in postischemic left ventricular remodeling 146
Variazioni diurne dell'effetto anticoagulante in corso di infusione continua e.v. di eparina non frazionata nell'uomo.Modificazioni indotte da acido acetilsalicilico per os. 145
Effetto dell' acido acetilsalicilico e della pentossifillina sulle variazioni diurne dell' attività anticoagulante dell' eparina non frazionata somministrata per infusione continua endovenosa nell' uomo 143
Early anti-thrombotic and anti-inflammatory actions of statins and fibrates -: time for adjuvant therapy in acute coronary syndromes? 142
Prospective Monitoring of Peripheral Blood CD26+ Leukemia Stem Cells in Chronic Myeloid Leukemia Patients from Time of TKI Discontinuation 136
Report of two cases of subconjunctival haemorrhage as first sign of post‐pregnancy acquired haemophilia a (AHA) 132
MEDICAL TREATMENT OF CRVO 131
Refractory Takayasu arteritis successfully treated with infliximab 130
Relationship between serum complement and different lipid disorders 129
New generation analysis of thrombin generation in retinal vein thrombosis 129
Peripheral Blood Flow-Cytometry Chronic Myeloid Leukemia Stem Cells Detection and Quantification during Tyrosine Kinase Inhibitors Therapy 128
Hypercoagulable state in hypercholesterolemic subjects assessed by platelet-dependent thrombin generation. In vitro effect of cerivastatin 119
Totale 20.144
Categoria #
all - tutte 62.998
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.998


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202183 0 0 0 0 0 0 0 0 0 0 0 83
2021/20221.328 104 162 94 161 70 22 63 36 59 128 122 307
2022/20231.842 112 147 274 234 172 373 33 156 186 30 97 28
2023/20241.531 57 36 123 74 53 464 501 34 16 39 41 93
2024/20252.848 66 142 286 146 372 142 52 147 233 114 336 812
2025/20266.940 529 993 1.018 801 1.363 281 734 198 261 407 215 140
Totale 21.105